Last reviewed · How we verify
Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever (Crimean-Congo Hemorrhagic Fever or Lassa Fever)
Is ribavirin a therapeutic option for patients with a probable or suspected case of viral hemorrhagic fever?
Details
| Lead sponsor | U.S. Army Medical Research and Development Command |
|---|---|
| Phase | NA |
| Status | ENROLLING_BY_INVITATION |
| Enrolment | 30 |
| Start date | 2016-06-16 |
| Completion | 2028-12 |
Conditions
- Viral Hemorrhagic Fever
Interventions
- Ribavirin
Primary outcomes
- Adverse reactions — 5 years
Countries
Germany